Conciseness

The body is mostly dense, non-generic material (API calls, field names, scoring interpretation), but the same caveats are repeated near-verbatim three times — "NOT confidence scores but relative ranking metrics" (line 220), "Scores rank relative, not absolute confidence" (line 271), and "Scores are relative, not absolute" (line 372); the "under-studied diseases score lower" point and the "no authentication" point are likewise each repeated three times, and the Limitations section largely restates Best Practices. This is more than 'minor instances' of padding, so it sits at anchor 3 rather than 4.

Actionability

Every workflow step ships a copy-paste-ready Python call to the bundled script with real arguments (e.g. `get_target_disease_evidence(ensembl_id="ENSG00000157764", efo_id="EFO_0000249")`), the returned fields are enumerated, and the raw GraphQL endpoint is given for custom queries. This fully matches anchor 5: fully executable examples covering the common cases.

Workflow Clarity

The 7-step core workflow and the four numbered Common Workflows give a clear, well-sequenced process, and there is an error-recovery loop ("re-check the live schema when a query fails... inspect the current schema rather than returning an empty result"). It is not 5 because validation checkpoints are stated in a separate versioning section rather than embedded as explicit validate-and-retry steps inside the workflows.

Progressive Disclosure

The SKILL.md is a well-organized overview with clearly signaled, one-level-deep references — `references/api_reference.md`, `references/evidence_types.md`, and `references/target_annotations.md` all exist as real files, contain the bulk detail (79–401 lines), and do not nest further references; `scripts/query_opentargets.py` is likewise real and documented. Content is appropriately split and easy to navigate, matching anchor 5.

Specificity

The description lists multiple concrete capabilities — "target-disease associations, drug target discovery, tractability/safety data, genetics/omics evidence, known drugs" — giving comprehensive, specific coverage of the skill's actions rather than vague language. This matches the anchor 'Lists multiple specific concrete actions; comprehensive coverage'; it is not score 4 because no capability area is noticeably missing.

Completeness

The 'what' is clearly and concretely answered, but there is no "Use when..." clause or equivalent explicit trigger guidance, which caps completeness at 3 per the judging guidelines. It is not score 4 because the 'when' is entirely absent, not merely implicit.

Trigger Term Quality

Good keyword coverage including natural terms users would say: "Open Targets", "drug target discovery", "tractability", "known drugs", "therapeutic target identification". It falls short of anchor 5 because common variations users might say — e.g. "gene targets", "target prioritization", "drug repurposing" — are missing.

Distinctiveness Conflict Risk

"Query Open Targets Platform" names a specific, well-known resource, creating a clear niche with distinct triggers and minimal conflict risk with other skills. Periphery terms like "genetics/omics evidence" overlap slightly with general bioinformatics skills, but the platform anchor keeps it distinct.